Follow
Laura Rodriguez de la Fuente
Laura Rodriguez de la Fuente
Children's Cancer Institute
Verified email at ccia.org.au
Title
Cited by
Cited by
Year
NK cell-based glioblastoma immunotherapy
I Golán, L Rodriguez de la Fuente, JA Costoya
Cancers 10 (12), 522, 2018
662018
Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype
F Valdes-Mora, R Salomon, BS Gloss, AMK Law, J Venhuizen, L Castillo, ...
Cell Reports 35 (2), 2021
482021
Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells
MA Fernandes, JO Eloy, MT Luiz, SLR Junior, JC Borges, LR de la Fuente, ...
Colloids and Surfaces A: Physicochemical and Engineering Aspects 611, 125806, 2021
362021
Advancements in 3D cell culture systems for personalizing anti-cancer therapies
AMK Law, L Rodriguez de la Fuente, TJ Grundy, G Fang, F Valdes-Mora, ...
Frontiers in Oncology 11, 782766, 2021
352021
Mammary tumor organoid culture in non‐adhesive alginate for luminal mechanics and high‐throughput drug screening
G Fang, H Lu, L Rodriguez de la Fuente, AMK Law, G Lin, D Jin, ...
Advanced Science 8 (21), 2102418, 2021
352021
Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancer
LR de la Fuente, AMK Law, D Gallego-Ortega, F Valdes-Mora
STAR protocols 2 (4), 100841, 2021
112021
Rapid metabolomic screening of cancer cells via high-throughput static droplet microfluidics
P Radfar, L Ding, LR de la Fuente, H Aboulkheyr, D Gallego-Ortega, ...
Biosensors and Bioelectronics 223, 114966, 2023
52023
Proteomics profiling identifies extracellular vesicles’ cargo associated with tumour cell induced platelet aggregation
N McNamee, LR de la Fuente, MJ Santos-Martinez, L O’Driscoll
BMC cancer 22 (1), 1023, 2022
32022
Development of a biosensor based on a new marine luciferase fused to an affibody to assess Her2 expression in living cells
LR de la Fuente, IG Cancela, ÁM Estévez-Salguero, P Iglesias, ...
Analytica Chimica Acta 1221, 340084, 2022
22022
ALTEN: A High‐Fidelity Primary Tissue‐Engineering Platform to Assess Cellular Responses Ex Vivo
AMK Law, J Chen, Y Colino‐Sanguino, LR Fuente, G Fang, SM Grimes, ...
Advanced Science 9 (21), 2103332, 2022
22022
Opera-gsam: Big data processing framework for umi sequencing at high scalability and efficiency
PV Caderno, FM Awaysheh, Y Colino-Sanguino, LR De La Fuente, ...
2023 IEEE/ACM 23rd International Symposium on Cluster, Cloud and Internet …, 2023
12023
Systematic comparison of high throughput Single-Cell RNA-Seq platforms in complex tissues
Y Colino Sanguino, L Rodriguez de la Fuente, B Gloss, AMK Law, ...
bioRxiv, 2023.04. 04.535585, 2023
12023
Development of novel immunotherapy strategies in advanced stage cancers
L Rodriguez de la Fuente
UNSW Sydney, 2023
2023
B. Rawat, Danda 26 Buzmakov, Aleksey 249 Byna, Suren 340 Cabaleiro, José C. 160
F Abdullah, M Adhikari, S Ahmad, M Al-Hawawreh, K Ali, FM Alotaibi, ...
The system can't perform the operation now. Try again later.
Articles 1–14